Carbamazepine Capsule, Extended Release
Product Images NDC 0904-6885

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0904-6885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caf9aa7a 4c9e 456a Bd02 06cc8453139c 00

Carbamazepine 200 mg extended-release capsules packaging label by Major Pharmaceuticals. The label includes dosage information, pharmacist dispensing instructions, and a count of 30 capsules per unit dose package. Warnings and storage instructions are provided, emphasizing prescription use and containment details.*

FDA Label Image

Carbamazepine-figure-1 (Carbamazepine Figure 1)

Chemical structure of the active ingredient carbamazepine, showing its tricyclic dibenzazepine ring system with an amide group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.